Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.

Wu J, Wang J, Bai X, Liu Y, Ao Y, Liu J, Yang H, Zheng W

Open source

DOI
10.1093/rheumatology/keag489
Published
2026 Sep 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag489,
  title = {Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.},
  author = {Wu J and Wang J and Bai X and Liu Y and Ao Y and Liu J and Yang H and Zheng W},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag489},
  url = {https://doi.org/10.1093/rheumatology/keag489}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.
AU  - Wu J
AU  - Wang J
AU  - Bai X
AU  - Liu Y
AU  - Ao Y
AU  - Liu J
AU  - Yang H
AU  - Zheng W
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag489
UR  - https://doi.org/10.1093/rheumatology/keag489
ER  - 

APA

J, W., J, W., X, B., Y, L., Y, A., J, L., H, Y., & W, Z. (2026). Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag489

Source records